Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 3:46:1-14.
doi: 10.1016/j.athplu.2021.10.003. eCollection 2021 Dec.

Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review

Affiliations
Review

Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review

Federico Biscetti et al. Atheroscler Plus. .

Abstract

Background and aims: The increasing prevalence of diabetes mellitus is causing a massive growth of peripheral artery disease incidences, a disabling complication of diabetic atherosclerosis, which leads often to the amputation of the affected limb. Critical limb ischemia is the terminal disease stage, which requires a prompt intervention to relieve pain and save limbs. However, patients undergoing revascularization often suffer from cardiovascular, cerebrovascular and major adverse limb events with poor outcomes. Furthermore, the same procedure performed in apparently similar patients has various outcomes and lack of an outcome predictive support causes a high lower limb arterial revascularization rate with disastrous effects for patients. We collected the main risk factors of major adverse limb events in a more readable and immediate format of the topic, to propose an overview of parameters to manage effectively peripheral artery disease patients and to propose basics of a new predictive tool to prevent from disabling vascular complications of the disease.

Methods: Most recent and updated literature about the prevalence of major adverse limb events in peripheral artery disease was reviewed to identify possible main predictors.

Results: In this article, we summarized major risk factors of limb revascularization failure and disabling vascular complications collecting those parameters principally responsible for major adverse limb events, which provides physio-pathological explanation of their role in peripheral artery disease.

Conclusion: We evaluated and listed a panel of possible predictors of MALE (Major Adverse Limb Event) in order to contribute to the development of a predictive score, based on a summary of the main risk factors reported in scientific articles, which could improve the management of peripheral artery disease by preventing vascular accidents.

Keywords: Critical limb ischemia; Diabetes mellitus; Major adverse limb event (MALE); Peripheral artery disease; Predictors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Predictors of Male: Main risk factors promoting the atherosclerotic process underlying peripheral artery disease. All possible predictors of major adverse limb events. MALE: Major Adverse Limb Event; BMP’s: Bone Morphogenetic Proteins; VSMCs: Vascular Smooth Muscle Cell; NFkB: Nuclear Factor Kappa-light-chain-enhancer of activated B cells; ROS: Reactive Oxygen Species; LDL: Low-Density Lipoprotein; eNOs: endothelial Nitric Oxide Synthase; MACE: Major Adverse Cardio/Cerebrovascular Event; ABI: Ankle-Brachial Index.

References

    1. Thiruvoipati T., Kielhorn C.E., Armstrong E.J. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. Jul 2015;6(7):961–969. doi: 10.4239/wjd.v6.i7.961. - DOI - PMC - PubMed
    1. Saeedi P., Petersohn I., Salpea P., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9. Diabetes Res Clin Pract. Nov 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Beckman J.A., Duncan M.S., Damrauer S.M., et al. Microvascular disease, peripheral artery disease, and amputation. Circulation. 08 2019;140(6):449–458. doi: 10.1161/CIRCULATIONAHA.119.040672. - DOI - PMC - PubMed
    1. Dicembrini I., Tomberli B., Nreu B., et al. Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. Jul 2019;153:138–144. doi: 10.1016/j.diabres.2019.05.028. - DOI - PubMed
    1. Badjatiya A., Merrill P., Buse J.B., et al. Clinical outcomes in patients with type 2 diabetes mellitus and peripheral artery disease: results from the EXSCEL trial. Circ Cardiovasc Interv. 12 2019;12(12) doi: 10.1161/CIRCINTERVENTIONS.119.008018. - DOI - PubMed

LinkOut - more resources